Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expert meeting report: towards a joint European roadmap to address the unmet needs and priorities of paediatric asthma patients on biologic therapy.
Golebski K, Dankelman LHM, Björkander S, Bønnelykke K, Brinkman P, Deschildre A, van Dijk YE, Fleming L, Grigg J, Hamelmann E, Hashimoto S, Kabesch M, Klevebro S, Maitland-van der Zee AH, Merid SK, Nieto A, Niggel J, Nilsson C, Potočnik U, Roberts G, Rusconi F, Saglani S, Valente E, van Drunen C, Wang G, Melén E, Vijverberg SJH. Golebski K, et al. ERJ Open Res. 2021 Nov 1;7(4):00381-2021. doi: 10.1183/23120541.00381-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34729368 Free PMC article.
Childhood asthma in the new omics era: challenges and perspectives.
Golebski K, Kabesch M, Melén E, Potočnik U, van Drunen CM, Reinarts S, Maitland-van der Zee AH, Vijverberg SJH; PERMEABLE consortium. Golebski K, et al. Curr Opin Allergy Clin Immunol. 2020 Apr;20(2):155-161. doi: 10.1097/ACI.0000000000000626. Curr Opin Allergy Clin Immunol. 2020. PMID: 31985545 Free PMC article. Review.
Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response.
Golebski K, Layhadi JA, Sahiner U, Steveling-Klein EH, Lenormand MM, Li RCY, Bal SM, Heesters BA, Vilà-Nadal G, Hunewald O, Montamat G, He FQ, Ollert M, Fedina O, Lao-Araya M, Vijverberg SJH, Maitland-van der Zee AH, van Drunen CM, Fokkens WJ, Durham SR, Spits H, Shamji MH. Golebski K, et al. Immunity. 2021 Feb 9;54(2):291-307.e7. doi: 10.1016/j.immuni.2020.12.013. Epub 2021 Jan 14. Immunity. 2021. PMID: 33450188 Free article. Clinical Trial.
Treating severe asthma: Targeting the IL-5 pathway.
Principe S, Porsbjerg C, Bolm Ditlev S, Kjaersgaard Klein D, Golebski K, Dyhre-Petersen N, van Dijk YE, van Bragt JJMH, Dankelman LLH, Dahlen SE, Brightling CE, Vijverberg SJH, Maitland-van der Zee AH. Principe S, et al. Among authors: golebski k. Clin Exp Allergy. 2021 Aug;51(8):992-1005. doi: 10.1111/cea.13885. Epub 2021 May 21. Clin Exp Allergy. 2021. PMID: 33887082 Free PMC article. Review.
Transcriptome changes during peanut oral immunotherapy and omalizumab treatment.
Björkander S, Merid SK, Brodin D, Brandström J, Fagerström-Billai F, van der Heiden M, Konradsen JR, Kabesch M, van Drunen CM, Golebski K, Maitland-van der Zee AH, Potočnik U, Vijverberg SJH, Nopp A, Nilsson C, Melén E. Björkander S, et al. Among authors: golebski k. Pediatr Allergy Immunol. 2022 Jan;33(1):e13682. doi: 10.1111/pai.13682. Epub 2021 Oct 31. Pediatr Allergy Immunol. 2022. PMID: 34669990 No abstract available.
Validation of volatile metabolites of pulmonary oxidative injury: a bench to bedside study.
Fenn D, Lilien TA, Hagens LA, Smit MR, Heijnen NFL, Tuip-de Boer AM, Neerincx AH, Golebski K, Bergmans DCJJ, Schnabel RM, Schultz MJ, Maitland-van der Zee AH, Brinkman P, Bos LDJ. Fenn D, et al. Among authors: golebski k. ERJ Open Res. 2023 Mar 20;9(2):00427-2022. doi: 10.1183/23120541.00427-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 36949963 Free PMC article.
36 results